project id: TCGA-PAAD; case submitter id: TCGA-2J-AABI; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.89; rna integrity number: 7.4; age at index: 55; days to birth: -20316; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1956; age at diagnosis: 20316; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 969.0; icd 10 code: C25.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Head of pancreas; synchronous malignancy: No; tissue or organ of origin: Head of pancreas; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Yes; cigarettes per day: 2.3013698630136985; pack years smoked: 42.0; years smoked: 31.0; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 774; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-2J-AABI-01A-12; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 2.0; percent necrosis: 25.0; percent neutrophil infiltration: 9.0; percent normal cells: 5.0; percent stromal cells: 40.0; percent tumor cells: 30.0; percent tumor nuclei: 30.0;